COLL vs EXPD · P/E 17, rev $181.9M vs P/E 26, rev $10.60B
Collegium Pharmaceutical Inc (COLL) versus Expeditors International of Washington, Inc. (EXPD) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Not investment advice. Open the COLL and EXPD stock pages for the full models.
Not investment advice.